Search:

FDA Approval Headlines from PR Newswire


< Go Back

ECPA Welcomes EFSA's Scientific Input but sees it as Late and Fears ED Rules will Crush Innovation in Farm Inputs
Quantel Medical Receives FDA Clearance for new Vitra Multispot Laser System
Mylan Launches Generic Version of Xopenex® Inhalation Solution
A Revolutionary Treatment for Burns & Bone Fractures
Anavex comments on FDA plan to expedite approval of new Alzheimer's drugs
Medigus Signed a Distribution Agreement in China
EAS Consulting Group, Experts in Quality Regulatory Services Related to FDA Issues, Announces Upcoming Dietary Supplement Seminars in Salt Lake City
Quidel and Life Technologies Receive FDA Clearance for Clostridium difficile Assay and QuantStudio™ Dx and 7500 Fast Dx Real-Time PCR Instruments
ThromboGenics' JETREA® Granted EU Approval for Vitreomacular Traction (VMT), Including When Associated With Macular Hole of Diameter Less Than or Equal to 400 Microns
Par Pharmaceutical Begins Shipment of Generic Luvox CR®
Neuralstem CEO, Richard Garr, Named To "Top 50 Global Stem Cell Influencers"
FDA Sets 26 August 2013 As New PDUFA Date For MOXDUO® NDA
Medigus Announces $8 Million Private Placement to OrbiMed
Tria Beauty, Inc. and Sephora Announce New U.S. Retail Partnership
SafeCode Drug Technologies Acquires Breakthrough Painless Injection Technology
FDA Grants Chimerix Fast Track Designation for CMX001 for the Prevention of Clinically Significant Cytomegalovirus Infection
invendo medical Announces US Market Entry Following Special 510(k) Clearance By FDA For Computer-Assisted Single-Use Colonoscopy System
Ampio Receives FDA Acceptance of its Patient Outcome for Premature Ejaculation (POPE) Questionnaire, Paving the Way for its US Pivotal Trial on Zertane™
Food Micro-Fifth Edition: Microbiology Testing in the US Food Industry
Wake Forest Innovations Announces New Commercialization Developments
Actavis Confirms Generic Exelon® Patch Patent Challenge
InspireMD Files Amended Registration Statement for Proposed Public Offering of Common Stock
Galectin Therapeutics Inc. Receives OK from FDA to Proceed with First Human Clinical Trial for Treatment of Fatty Liver Disease with Advanced Fibrosis
Tenaxis Medical®, Inc. Receives FDA Approval for its ArterX® Surgical Sealant
FDA Issues Complete Response Letter for XARELTO® (rivaroxaban) for the Reduction of Cardiovascular Events in Patients with Acute Coronary Syndrome
FDA Clears First Blood Glucose Monitoring System To Automatically Send Results Wirelessly Via Bluetooth® Technology to iOS Devices
Arena Pharmaceuticals Provides Corporate Update and Reviews Fourth Quarter and Full Year 2012 Financial Results
DMH International Announces FDA Approval of TouchPACS
Philips receives FDA clearance to market MicroDose SI mammography system
CSL Behring Receives FDA Approval to Expand the Indication for Corifact®
SynCardia's 50cc Total Artificial Heart Receives Two HUD Designations from the FDA for Destination Therapy and Pediatric Bridge to Transplant
U.S. ARKRAY Announces FDA Clearance of the Fully Automated Integrated Urine Analyzer AUTION HYBRID™ AU-4050
Cardioviva™ Heart Health Probiotic Achieves FDA Generally Recognized As Safe (GRAS) Status
Recall of Anemia Drug Omontys Rings Alarm Over Biosimilars
Surgical Theater, LLC™ Receives FDA Clearance for Surgery Rehearsal Platform™
Syneron Beauty Introduces the me smooth At-Home Hair Removal System
Shionogi Receives FDA Approval For Osphena™ (Ospemifene) For The Treatment Of Dyspareunia, A Symptom Of Vulvar And Vaginal Atrophy (VVA), Due To Menopause
Tandem Diabetes Care Announces FDA Clearance of t:connect Diabetes Management Application for Use with t:slim Insulin Pump
Bayer's Stivarga® (regorafenib) Tablets Approved by U.S. FDA for Treatment of Patients with Locally Advanced, Unresectable or Metastatic GIST
Actavis' Generic Suboxone® Receives FDA Approval
Lupin Receives FDA Approval for New Drug Application for SUPRAX® Oral Suspension, 500 mg/5mL
Lupin Receives FDA Approval for New Drug Application for SUPRAX® Oral Suspension, 500 mg/5mL
CSL Behring Announces New Vial Size of Privigen® for Treatment of Primary Immunodeficiency and Chronic Immune Thrombocytopenic Purpura
FDA Publicly Challenged to Support Unsubstantiated Claims Regarding Electronic Cigarettes
UCB Announces Regulatory Filings for Cimzia® (Certolizumab Pegol) to Treat Psoriatic Arthritis and Axial Spondyloarthritis
Perfect Your Physique
InSightec's ExAblate Neuro Receives the Go-ahead from FDA to Begin its Pivotal Phase III trial for Essential Tremor
Perrigo Confirms First to File Patent Challenge for Generic Version of Testosterone Gel 1.62%
Epiduo® Gel Becomes First Topical Prescription Acne Treatment Available For Children As Young As 9 Years Old
ElectroCore® Receives Australian and Colombian Regulatory Approval for GammaCore® Vagal Nerve Stimulation Therapy

< Prev Next >
PR Newswire - United Business Media